Cargando…

Biomarkers to Target Heterogeneous Breast Cancer Stem Cells

Breast cancer is the most common cancer and the second leading cause of death in U.S. women. Due to early detection and advanced treatment, the breast cancer death rate has been declining since 1990. However, disease recurrence is still the major obstacle in moving from therapy to truly curative tre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hwang-Verslues, Wendy W., Lee, Wen-Hwa, Lee, Eva Y.-H.P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2012
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072313/ https://www.ncbi.nlm.nih.gov/pubmed/24977105 http://dx.doi.org/10.4172/2155-9929.S8-006

Ejemplares similares

Multiple Lineages of Human Breast Cancer Stem/Progenitor Cells Identified by Profiling with Stem Cell Markers
por: Hwang-Verslues, Wendy W., et al.
Publicado: (2009)

Targeting IL-17B–IL-17RB signaling with an anti–IL-17RB antibody blocks pancreatic cancer metastasis by silencing multiple chemokines
por: Wu, Heng-Hsiung, et al.
Publicado: (2015)

TGF‐β1 secreted by Tregs in lymph nodes promotes breast cancer malignancy via up‐regulation of IL‐17RB
por: Huang, Shih‐Chia, et al.
Publicado: (2017)

Phenotypic Heterogeneity of Breast Cancer Stem Cells
por: Lorico, Aurelio, et al.
Publicado: (2011)

Cancer stem cell heterogeneity in hereditary breast cancer
por: Wicha, Max S
Publicado: (2008)

Targeted Therapy and Immunotherapy for Heterogeneous Breast Cancer
por: Sun, Xiaolu, et al.
Publicado: (2022)

Identification of FDA-approved Drugs Targeting Breast Cancer Stem Cells Along With Biomarkers of Sensitivity
por: Bhat-Nakshatri, Poornima, et al.
Publicado: (2013)

Intratumoral heterogeneity as a source of discordance in breast cancer biomarker classification
por: Allott, Emma H., et al.
Publicado: (2016)

Nanomedicine-Mediated Therapies to Target Breast Cancer Stem Cells
por: He, Lili, et al.
Publicado: (2016)

Breast Cancer Stem Cell Membrane Biomarkers: Therapy Targeting and Clinical Implications
por: Conde, Inês, et al.
Publicado: (2022)

Evaluation of Breast Cancer Stem Cells and Intratumor Stemness Heterogeneity in Triple-negative Breast Cancer as Prognostic Factors
por: Yang, Fang, et al.
Publicado: (2016)

Resolving breast cancer heterogeneity by searching reliable protein cancer biomarkers in the breast fluid secretome
por: Mannello, Ferdinando, et al.
Publicado: (2013)

Biomarkers Associated with Tumor Heterogeneity in Prostate Cancer()()
por: Yun, Jae Won, et al.
Publicado: (2018)

Breast Cancer Cells Induce Cancer-Associated Fibroblasts to Secrete Hepatocyte Growth Factor to Enhance Breast Tumorigenesis
por: Tyan, Shiaw-Wei, et al.
Publicado: (2011)

Heterogeneity of breast cancer stem cells as evidenced with Notch-dependent and Notch-independent populations
por: Wong, Nelson K Y, et al.
Publicado: (2012)

Nuclear Receptor HNF4α Binding Sequences are Widespread in Alu Repeats
por: Bolotin, Eugene, et al.
Publicado: (2011)

Active Targeting of Versatile Nanocomplex Using the Novel Biomarker of Breast Cancer Stem Cells
por: Koh, Eun-Young, et al.
Publicado: (2022)

Challenges for Triple Negative Breast Cancer Treatment: Defeating Heterogeneity and Cancer Stemness
por: Mahmoud, Rinad, et al.
Publicado: (2022)

Heterogeneity of Human Breast Stem and Progenitor Cells as Revealed by Transcriptional Profiling
por: Colacino, Justin A., et al.
Publicado: (2018)

Targeting Liver Cancer Stem Cells: An Alternative Therapeutic Approach for Liver Cancer
por: Lee, Hwa-Yong, et al.
Publicado: (2020)

Targeting cancer stem cells by using the nanoparticles
por: Hong, In-Sun, et al.
Publicado: (2015)

Editorial: Targeting Heterogeneity of Mesenchymal Stem Cells
por: Zhang, Qi, et al.
Publicado: (2022)

Cancer stem cell heterogeneity: origin and new perspectives on CSC targeting
por: Eun, Kiyoung, et al.
Publicado: (2017)

Breast Cancer Heterogeneity
por: Fumagalli, Caterina, et al.
Publicado: (2021)

Differential effects of SUMO1 and SUMO2 on circadian protein PER2 stability and function
por: Chen, Ling-Chih, et al.
Publicado: (2021)

Core clock gene BMAL1 and RNA-binding protein MEX3A collaboratively regulate Lgr5 expression in intestinal crypt cells
por: Cheng, Li-Tzu, et al.
Publicado: (2023)

Hypermethylation of CCND2 in Lung and Breast Cancer Is a Potential Biomarker and Drug Target
por: Hung, Chin-Sheng, et al.
Publicado: (2018)

The diverse metabolic heterogeneity of stem cells in a BRCA+/-breast cancer population
por: Gramatiuk, Svetlana Mykolaivna, et al.
Publicado: (2021)

Targeting Cancer Stem Cell Markers or Pathways: A Potential Therapeutic Strategy for Oral Cancer Treatment
por: Lee, Jin Woo, et al.
Publicado: (2021)

The role of clonal communication and heterogeneity in breast cancer
por: Martín-Pardillos, Ana, et al.
Publicado: (2019)

Biomarker heterogeneity between primary breast cancer and synchronous axillary lymph node metastases
por: Xi, Xun, et al.
Publicado: (2020)

Targeting Breast Cancer Stem Cells
por: Zhang, Lu, et al.
Publicado: (2023)

Kinome profiling reveals breast cancer heterogeneity and identifies targeted therapeutic opportunities for triple negative breast cancer
por: Al-Ejeh, Fares, et al.
Publicado: (2014)

THOR is a targetable epigenetic biomarker with clinical implications in breast cancer
por: Apolónio, Joana Dias, et al.
Publicado: (2022)

Radiotherapy diagnostic biomarkers in radioresistant human H460 lung cancer stem-like cells
por: Yun, Hong Shik, et al.
Publicado: (2016)

Heterogeneous nuclear ribonucleoprotein A/B: an emerging group of cancer biomarkers and therapeutic targets
por: Lu, Ya, et al.
Publicado: (2022)

Response of Breast Cancer Cells and Cancer Stem Cells to Metformin and Hyperthermia Alone or Combined
por: Lee, Hyemi, et al.
Publicado: (2014)

Reasons for breast cancer heterogeneity
por: Bertucci, François, et al.
Publicado: (2008)

Tumor Heterogeneity in Breast Cancer
por: Turashvili, Gulisa, et al.
Publicado: (2017)

A Novel Dual HDAC6 and Tubulin Inhibitor, MPT0B451, Displays Anti-tumor Ability in Human Cancer Cells in Vitro and in Vivo
por: Wu, Yi-Wen, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_jd9gacjildoi1rjb2rufp3326f